TOGA Podcast
By Thoracic Oncology Group Of Australasia (TOGA)
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 2
Reviews: 0
Episodes: 39
Description
Join TOGA to learn more about lung cancer.
Podcasts with leading experts.
Patient Interviews.
Trial updates.
| Episode | Date |
|---|---|
|
Lung Cancer Nurses: Essential, Beneficial and a Key Link In Lung Cancer Screening
|
Apr 22, 2024 |
|
Underutilisation of Radiotherapy in Lung Cancer Treatment
|
Mar 27, 2024 |
|
Revolutionising Lung Cancer Healthcare with AI: Unlocking the Future
|
Feb 28, 2024 |
|
Antibody Drug Conjugates (ADCs) – An Emerging Treatment Platform in Lung Cancer
|
Dec 15, 2023 |
|
Lung cancer Screening and Moving from Concept to Roll Out
|
Oct 31, 2023 |
|
Early Recovery After Surgery - Guidelines and Multidisciplinary Considerations
|
Oct 06, 2023 |
|
Nature and nurture: lung cancer risk and implications for future screening
|
Aug 10, 2023 |
|
Operability in Stage III NSCLC
|
Jul 04, 2023 |
|
NSCLC and KRAS Mutations
|
Jun 06, 2023 |
|
Treatment Considerations in ALK-Positive NSCLC
|
Apr 21, 2023 |
|
Celebrating Female Leadership in Medical Research
|
Mar 08, 2023 |
|
Brain metastases in NSCLC
|
Feb 23, 2023 |
|
NGS panels in lung cancer
|
Dec 20, 2022 |
|
Lung Cancer Screening and its impact on patient care in Australia
|
Dec 07, 2022 |
|
The Management of Stage III NSCLC
|
Oct 31, 2022 |
|
The Changing Course of Outcomes in Early Stage NSCLC: Surgical and Respiratory Medicine Considerations
|
Oct 12, 2022 |
|
Cardiotoxicity and Radiation Therapy - Considerations for Lung Cancer
|
Sep 01, 2022 |
|
Accelerating Progress in Oncogene-driven Lung Cancer
|
Aug 09, 2022 |
|
Access to Molecular Diagnostics and Treatments Across ANZ: The Past, Present, Future
|
Jul 24, 2022 |
|
Practical smoking cessation advice for health care providers
|
May 30, 2022 |
|
Consider Every Trial as a TeleTrial
|
Apr 30, 2022 |
|
EGFR Update: Improving Outcomes in EGFR-Mutated Non-Small-Cell Cancer
|
Mar 29, 2022 |
|
The need for a National Clinical Quality Registry in Lung Cancer
|
Feb 22, 2022 |
|
ALK treatment considerations in NSCLC
|
Dec 08, 2021 |
|
Stigma and Nihilism In Lung Cancer : A Call to Action
|
Nov 23, 2021 |
|
Challenging the Lung Cancer Stigma
|
Nov 08, 2021 |
|
The Value of Comprehensive Genomic Profiling in Lung Cancer
|
Oct 17, 2021 |
|
Inflammation And Its Impact On The Development & Treatment Of Lung Cancer
|
Sep 24, 2021 |
|
Optimising Diagnosis & Treatment Pathways For Lung Cancer Patients
|
Jul 30, 2021 |
|
Long Term Survivorship: Thriving with Metastatic Lung Cancer
|
Jun 24, 2021 |
|
Women and Lung Cancer: The Rising Tide
|
May 14, 2021 |
|
Practical Perspectives: Shifting the Needle in Small Cell Lung Canceer
|
Apr 01, 2021 |
|
Lung cancer screening works!
|
Mar 01, 2021 |
|
Dreaming of Better Treatments for Mesothelioma
|
Feb 16, 2021 |
|
Lung Cancer Careers: Preceptorship Reflections
|
Dec 13, 2020 |
|
Cancer won't wait: A Cancer Australia Perspective
|
Nov 25, 2020 |
|
2020 Wrap: Remarkable Progress In Diagnosing & Treating Lung Cancer
|
Nov 18, 2020 |
|
Redefining Survival In Lung Cancer: Meet Alexandra
|
Nov 10, 2020 |
|
Improving Survival In Oncogene Driven Lung Cancer
|
Nov 10, 2020 |